These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 24245692)
1. Suppression of NF-κB signaling and P-glycoprotein function by gambogic acid synergistically potentiates adriamycin -induced apoptosis in lung cancer. Wang LH; Yang JY; Yang SN; Li Y; Ping GF; Hou Y; Cui W; Wang ZZ; Xiao W; Wu CF Curr Cancer Drug Targets; 2014; 14(1):91-103. PubMed ID: 24245692 [TBL] [Abstract][Full Text] [Related]
2. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974 [TBL] [Abstract][Full Text] [Related]
3. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells. Nokihara H; Yano S; Nishioka Y; Hanibuchi M; Higasida T; Tsuruo T; Sone S Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730 [TBL] [Abstract][Full Text] [Related]
4. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1. Kim MK; Jeon YK; Woo JK; Choi Y; Choi DH; Kim YH; Kim CW Mol Cancer; 2011 Aug; 10():98. PubMed ID: 21843371 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells. Tsai AC; Pai HC; Wang CY; Liou JP; Teng CM; Wang JC; Pan SL Br J Pharmacol; 2014 Jan; 171(1):122-33. PubMed ID: 24116948 [TBL] [Abstract][Full Text] [Related]
6. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway. Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615 [No Abstract] [Full Text] [Related]
7. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models. Gao ZW; Zhang DL; Guo CB Curr Cancer Drug Targets; 2010 Nov; 10(7):705-15. PubMed ID: 20578985 [TBL] [Abstract][Full Text] [Related]
8. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. He D; Xu Q; Yan M; Zhang P; Zhou X; Zhang Z; Duan W; Zhong L; Ye D; Chen W BMC Cancer; 2009 Sep; 9():343. PubMed ID: 19778460 [TBL] [Abstract][Full Text] [Related]
9. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin. Hung LVM; Moon JY; Ryu JY; Cho SK Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid. Li Y; Xing D; Chen Q; Chen WR Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232 [TBL] [Abstract][Full Text] [Related]
13. Lumbrokinase Extracted from Hua C; Guo Z; Dai M; Zhou J; Ge H; Xue G; Xu F; Ru L; Lv K; Zhang G; Zheng L; Wang M; Teng Y; Yu W; Guo W Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062456 [TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo. Zhang D; Qiu L; Jin X; Guo Z; Guo C Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264 [TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764 [TBL] [Abstract][Full Text] [Related]
17. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway. Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934 [TBL] [Abstract][Full Text] [Related]
18. Gambogic acid-induced autophagy in nonsmall cell lung cancer NCI-H441 cells through a reactive oxygen species pathway. Ye L; Zhou J; Zhao W; Jiao P; Ren G; Wang S J Cancer Res Ther; 2018 Dec; 14(Supplement):S942-S947. PubMed ID: 30539827 [TBL] [Abstract][Full Text] [Related]
19. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance. Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648 [TBL] [Abstract][Full Text] [Related]
20. Gambogic Acid Induces Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells by Suppressing Notch Signaling. Zhu M; Wang M; Jiang Y; Wu H; Lu G; Shi W; Cong D; Song S; Liu K; Wang H Med Sci Monit; 2018 Oct; 24():7146-7151. PubMed ID: 30293083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]